Trainings By Informa Markets in India
Informa


Understanding the Global Regulatory Perspective to tackle the Nitrosamines in Drug Substances and Drug Products

Duration - 67 Minutes

About the course

Evolving demand to identify nitrosamines at right levels
  • Key regulatory requirements to strategize identification of toxic impurities
  • Futuristic regulatory approach
  • Possible drug molecules expected to be scrutinized for these impurities

Speaker Profile

Dr. BM Rao

VP & Head – Analytical Science & Technology & CQC
Dr. Reddys Laboratories

Dr. Ulrich Rose

Head of Division A, Deputy Head
European Pharmacopoeia Department at the EDQM, Council of Europe

Dr. Edward Gump

Senior Director - Chemical Medicines
USP

Dr. Aloka Srinivasan

Principal - RAAHA LLC.
Former USFDA

Dr. Atul Awasthi

Director
APAC Analytical Tech Global Tech and Engr group. Pfizer